The IV treatment of the siRNA-loaded nanoparticles reduced kidney injury molecule-1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) by three- and four-fold in the AKI mouse. This evidence concerns the gene LCN2 and acute kidney injury.